LDR | |
01517nam a22003017 4500 |
001 |
|
003183413 |
003 |
|
MiAaHDL |
005 |
|
20241227000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
970929s1978 ncu 000 0 eng d |
035 |
⊔ |
⊔ |
‡a(MiU)990031834130106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990031834130106381
|
035 |
⊔ |
⊔ |
‡z(MiU)MIU01000000000000003183413-goog
|
035 |
⊔ |
⊔ |
‡a(OCoLC)37664839
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph003183413
|
040 |
⊔ |
⊔ |
‡aEYM
‡cEYM
‡dUtOrBLW
|
100 |
1 |
⊔ |
‡aHarris, Benjamin S. H.
|
245 |
1 |
0 |
‡aFollow-up of patients receiving diagnostic doses of 131 iodine during childhood /
‡cBenjamin S.H. Harris, Martha L. Smith, Mildred I. Holt ; project officer, William C. Nelson.
|
260 |
⊔ |
⊔ |
‡aResearch Triangle Park, N.C. :
‡bHealth Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency,
‡c1978.
|
300 |
⊔ |
⊔ |
‡ax, 47 p. ;
‡c29 cm.
|
336 |
⊔ |
⊔ |
‡atext
‡btxt
‡2rdacontent
|
337 |
⊔ |
⊔ |
‡aunmediated
‡bn
‡2rdamedia
|
338 |
⊔ |
⊔ |
‡avolume
‡bnc
‡2rdacarrier
|
490 |
0 |
⊔ |
‡aEPA 600/1 ;
‡v78-059
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aThyroid Neoplasms
‡xetiology.
‡0http://id.nlm.nih.gov/mesh/D013964Q000209
|
650 |
⊔ |
2 |
‡aIodine Isotopes
‡xadverse effects.
‡0http://id.nlm.nih.gov/mesh/D007456Q000009
|
650 |
⊔ |
0 |
‡aThyroid gland
‡xCancer
‡xEtiology.
‡0http://id.loc.gov/authorities/subjects/sh2010010414
|
650 |
⊔ |
0 |
‡aIodine
‡xIsotopes
‡xPhysiological effect.
|
899 |
⊔ |
⊔ |
‡a39015041349179
|
CID |
⊔ |
⊔ |
‡a003183413
|
DAT |
0 |
⊔ |
‡a20241218071609.0
‡b20241227000000.0
|
DAT |
1 |
⊔ |
‡a20250103022134.0
‡b2025-01-03T15:38:07Z
|
DAT |
2 |
⊔ |
‡a2023-06-30T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡cmiu
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990031834130106381
‡aMiU
‡bSDR
‡cMIU
‡f003183413
‡pmdp.39015041349179
‡sMIU
‡1990031834130106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20250103
‡sgoogle
‡umdp.39015041349179
‡y1978
‡rpdus
‡qgfv
|